Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 10 results for "zurich challenge"

Credit Suisse CEO says has good reason to believe conditions improving

Credit Suisse CEO says has good reason to believe conditions i...

ZURICH (Reuters) - Challenging market conditions could be set to improve, Credit Suisse Chief Executive Tidjane Thiam said on Wednesday. Business Standard, 2 months ago

30 images for zurich challenge

Philanthropy News Digest, 3 weeks ago
Yahoo! UK and Ireland, 3 weeks ago
Tanzania Today, 4 weeks ago
Deutsche Welle, 1 month ago
France24, 2 months ago
France24, 2 months ago
Citywire Selector, 2 months ago
Tanzania Today, 2 months ago
Commercial Risk Europe, 3 months ago
Biz Community, 5 months ago

Credit Suisse's Thiam steps up cost cuts, lowers profit goals

Credit Suisse pledged to cut another 1 billion Swiss francs ($991 million) in costs and pared back profit targets amid challenging markets which have made it harder for banks to make money. Just over a year since Chief Executive Tidjane Thiam laid out his ...
 Reuters2 months ago Credit Suisse to cut costs further, lowers targets  Business Standard2 months ago Corrected: Credit Suisse's Thiam steps up cost cuts, lowers profit goals  Sify2 months ago

GVK Group wins Rs 16K crore Navi Mumbai airport bid

The Rs 16,000-crore greenfield Navi Mumbai international airport project on Monday moved a step closer to reality a decade after it was cleared, with GVK Group bagging the financial bid to build and operate the facility. GVK Group that runs the swanky MIAL (Mumbai international airport) pipped rival GMR Group to bag the contract for the proposed facility in Navi Mumbai which will ease the severe congestion at the Chhatrapati Shivaji International Airport. The new airport was proposed in 1997 ...
 Rediff.com1 week ago Tata, GMR giving Navi Mumbai Int'l Airport a miss?  DNA1 month ago

Novartis says court battle will delay its Enbrel copy until 2018 at least

The Novartis copy of Amgen's blockbuster psoriasis drug Enbrel will not go on sale before 2018 at the earliest because of the U.S. company's patent protection challenge, the Swiss drugmaker's head of generics told Reuters. Though the U.S. Food and Drug ...
 Reuters4 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less